Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,083 | 295,394 | 74,356 | 222,080 | 115,358 |
| Marketable Securities | 428,830 | 282,189 | 410,041 | 224,865 | 177,822 |
| Receivables | 11,237 | N/A | 3,474 | N/A | N/A |
| Inventories | 366 | N/A | N/A | N/A | N/A |
| TOTAL | $603,057 | $580,876 | $489,786 | $448,396 | $298,864 |
| Non-Current Assets | |||||
| PPE Net | N/A | 8 | 20 | 278 | 192 |
| Investments And Advances | 119,520 | 29,829 | 5,469 | 0 | 0 |
| Other Non-Current Assets | 2,239 | 2,167 | 1,961 | 983 | 1,557 |
| TOTAL | $121,759 | $32,004 | $7,450 | $1,261 | $1,749 |
| Total Assets | $724,816 | $612,880 | $497,236 | $449,657 | $300,613 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,116 | N/A | N/A | N/A | 2,285 |
| Accounts payable and accrued liabilities | 31,164 | 17,193 | 4,350 | 5,669 | 3,508 |
| Accrued Expenses | 59,789 | 39,856 | 24,276 | 14,465 | 11,246 |
| Other current liabilities | N/A | N/A | N/A | 187 | N/A |
| TOTAL | $103,549 | $58,096 | $29,065 | $20,683 | $18,872 |
| Non-Current Liabilities | |||||
| Long Term Debt | 331,565 | N/A | N/A | 19,895 | 17,834 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,517 |
| Other Non-Current Liabilities | 1,578 | 578 | 709 | 711 | 102 |
| TOTAL | $333,143 | $588 | $722 | $20,606 | $29,553 |
| Total Liabilities | $436,692 | $58,684 | $29,787 | $41,289 | $48,425 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,024 | 84,965 | 68,443 | 55,012 | 48,236 |
| Common Shares | 9 | 8 | 7 | 6 | 5 |
| Retained earnings | -1,221,158 | -902,400 | -693,040 | -543,702 | -568,628 |
| Other shareholders' equity | 163 | 218 | -806 | 45 | -4 |
| TOTAL | $288,124 | $554,196 | $467,449 | $408,368 | $252,188 |
| Total Liabilities And Equity | $724,816 | $612,880 | $497,236 | $449,657 | $300,613 |